Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;35:936-941

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sherman, D. L.
Right arrow Articles by Vita, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sherman, D. L.
Right arrow Articles by Vita, J. A.
Related Collections
Right arrow Hypertension - basic studies
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2000;35:936.)
© 2000 American Heart Association, Inc.


Scientific Contributions

Pharmacological Concentrations of Ascorbic Acid Are Required for the Beneficial Effect on Endothelial Vasomotor Function in Hypertension

Debra L. Sherman; John F. Keaney, Jr; Elizabeth S. Biegelsen; Stephen J. Duffy; Jay D. Coffman; Joseph A. Vita

From the Evans Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Mass.

Correspondence Joseph A. Vita, MD, Cardiology C-8, Boston Medical Center, 88 E Newton St, Boston, MA 02118. E-mail jvita{at}bu.edu

Abstract—Increased production of superoxide anion may contribute to impaired bioactivity of endothelium-derived nitric oxide in hypertension. Ascorbic acid is capable of scavenging superoxide anion; however, experimental studies have shown that high physiological concentrations (>1 mmol/L) of ascorbic acid are required to prevent superoxide-mediated vascular dysfunction. To seek kinetic evidence that superoxide anion contributes to endothelial vasomotor dysfunction in human hypertension, we examined the effects of 2.4 or 24 mg/min ascorbic acid intra-arterial infusions on forearm blood flow responses to methacholine or sodium nitroprusside in 30 patients with hypertension and 22 age-matched controls. Endothelium-dependent vasodilation to methacholine was significantly impaired in the hypertensive patients, with a response to the highest dose of methacholine (10 µg/min) of 12.3±6.7 compared with 16.1±5.8 mL · min-1 · dL tissue-1 in the controls (P<0.001). The response to sodium nitroprusside was equivalent in the 2 groups. Ascorbic acid at 24 mg/min significantly improved the forearm blood flow response to methacholine in hypertensive patients with a peak response of 16.1±7.1 mL · min-1 · dL tissue-1 (P=0.001). This dose produced a cephalic vein ascorbic acid concentration of 3.2±1.4 mmol/L. In contrast, ascorbic acid at 2.4 mg/min had no effect on the methacholine response. Ascorbic acid at both doses had no effect on the vasodilator response to sodium nitroprusside in hypertensive patients or the methacholine response in the controls. These results agree with the predicted kinetics for superoxide anion–mediated impairment of endothelium-derived nitric oxide action. Thus, superoxide anion may contribute to impaired endothelium-dependent vasodilation in patients with hypertension.


Key Words: ascorbic acid • endothelium • hypertension, essential • superoxide




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. Garry, D. H. Edwards, I. F. Fallis, R. L. Jenkins, and T. M. Griffith
Ascorbic acid and tetrahydrobiopterin potentiate the EDHF phenomenon by generating hydrogen peroxide
Cardiovasc Res, November 1, 2009; 84(2): 218 - 226.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Dejam, C. J. Hunter, C. Tremonti, R. M. Pluta, Y. Y. Hon, G. Grimes, K. Partovi, M. M. Pelletier, E. H. Oldfield, R. O. Cannon III, et al.
Nitrite Infusion in Humans and Nonhuman Primates: Endocrine Effects, Pharmacokinetics, and Tolerance Formation
Circulation, October 16, 2007; 116(16): 1821 - 1831.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
S. M. Shenouda and J. A. Vita
Effects of Flavonoid-Containing Beverages and EGCG on Endothelial Function
J. Am. Coll. Nutr., August 1, 2007; 26(4): 366S - 372S.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. E. Schmieder, C. Delles, A. Mimran, J. P. Fauvel, and L. M. Ruilope
Impact of Telmisartan Versus Ramipril on Renal Endothelial Function in Patients With Hypertension and Type 2 Diabetes
Diabetes Care, June 1, 2007; 30(6): 1351 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. K. Nightingale, J. G. Crilley, N. C. Pegge, E. A. Boehm, C. Mumford, D. J. Taylor, P. Styles, K. Clarke, and M. P. Frenneaux
Chronic oral ascorbic acid therapy worsens skeletal muscle metabolism in patients with chronic heart failure
Eur J Heart Fail, March 1, 2007; 9(3): 287 - 291.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. George, E. Carr, J. Davies, J.J.F. Belch, and A. Struthers
High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid
Circulation, December 5, 2006; 114(23): 2508 - 2516.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Grebe, H. J. Eisele, N. Weissmann, C. Schaefer, H. Tillmanns, W. Seeger, and R. Schulz
Antioxidant Vitamin C Improves Endothelial Function in Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 897 - 901.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Chen, R. J. Karne, G. Hall, U. Campia, J. A. Panza, R. O. Cannon III, Y. Wang, A. Katz, M. Levine, and M. J. Quon
High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H137 - H145.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Mak, C. B. Overgaard, and G. E. Newton
Effect of vitamin C and L-NMMA on the inotropic response to dobutamine in patients with heart failure
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2424 - H2428.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. J. Duffy, E. S. Biegelsen, R. T. Eberhardt, D. F. Kahn, B. A. Kingwell, and J. A. Vita
Low-Renin Hypertension With Relative Aldosterone Excess Is Associated With Impaired NO-Mediated Vasodilation
Hypertension, October 1, 2005; 46(4): 707 - 713.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Heitzer, S. Baldus, Y. von Kodolitsch, V. Rudolph, and T. Meinertz
Systemic Endothelial Dysfunction as an Early Predictor of Adverse Outcome in Heart Failure
Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1174 - 1179.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Monahan, I. Eskurza, and D. R. Seals
Ascorbic acid increases cardiovagal baroreflex sensitivity in healthy older men
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2113 - H2117.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Kinlay, D. Behrendt, J. C. Fang, D. Delagrange, J. Morrow, J. L. Witztum, N. Rifai, A. P. Selwyn, M. A. Creager, and P. Ganz
long-term effect of combined vitamins e and c on coronary and peripheral endothelial function
J. Am. Coll. Cardiol., February 18, 2004; 43(4): 629 - 634.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Mak and G. E. Newton
Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H789 - H795.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. K. Nightingale, M. Schmitt, M. P. Frenneaux, G. Piccirillo, M. Nocco, A. Moise, M. Lionetti, C. Naso, and S. D. C. V. Marigliano
Letter: Vitamin C in Heart Failure: Hype or Hope?
Hypertension, February 1, 2004; e6(2): .
[Full Text] [PDF]


Home page
HypertensionHome page
G. E. Callera, R. M. Touyz, S. A. Teixeira, M. N. Muscara, M. H. C. Carvalho, Z. B. Fortes, D. Nigro, E. L. Schiffrin, and R. C. Tostes
ETA Receptor Blockade Decreases Vascular Superoxide Generation in DOCA-Salt Hypertension
Hypertension, October 1, 2003; 42(4): 811 - 817.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. E. Widlansky, D. T. Price, N. Gokce, R. T. Eberhardt, S. J. Duffy, M. Holbrook, C. Maxwell, J. Palmisano, J. F. Keaney Jr, J. D. Morrow, et al.
Short- and Long-Term COX-2 Inhibition Reverses Endothelial Dysfunction in Patients With Hypertension
Hypertension, September 1, 2003; 42(3): 310 - 315.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. F. Kahn, S. J. Duffy, D. Tomasian, M. Holbrook, L. Rescorl, J. Russell, N. Gokce, J. Loscalzo, and J. A. Vita
Effects of Black Race on Forearm Resistance Vessel Function
Hypertension, August 1, 2002; 40(2): 195 - 201.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Pleiner, G. Schaller, F. Mittermayer, M. Bayerle-Eder, M. Roden, and M. Wolzt
FFA-Induced Endothelial Dysfunction Can Be Corrected by Vitamin C
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2913 - 2917.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Rathaus and J. Bernheim
Oxygen species in the microvascular environment: regulation of vascular tone and the development of hypertension
Nephrol. Dial. Transplant., February 1, 2002; 17(2): 216 - 221.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Wu, D. Lamontagne, and J. de Champlain
Antioxidative Properties of Acetylsalicylic Acid on Vascular Tissues From Normotensive and Spontaneously Hypertensive Rats
Circulation, January 22, 2002; 105(3): 387 - 392.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Gokce, M. Holbrook, S. J. Duffy, S. Demissie, L.A. Cupples, E. Biegelsen, J. F. Keaney Jr, J. Loscalzo, and J. A. Vita
Effects of Race and Hypertension on Flow-Mediated and Nitroglycerin-Mediated Dilation of the Brachial Artery
Hypertension, December 1, 2001; 38(6): 1349 - 1354.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. Chen, R. M. Touyz, J. B. Park, and E. L. Schiffrin
Antioxidant Effects of Vitamins C and E Are Associated With Altered Activation of Vascular NADPH Oxidase and Superoxide Dismutase in Stroke-Prone SHR
Hypertension, September 1, 2001; 38(3): 606 - 611.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. J. Duffy, E. S. Biegelsen, M. Holbrook, J. D. Russell, N. Gokce, J. F. Keaney Jr, and J. A. Vita
Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease
Circulation, June 12, 2001; 103(23): 2799 - 2804.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Grossmann, D. Dobrev, H. M. Himmel, U. Ravens, and W. Kirch
Ascorbic Acid-Induced Modulation of Venous Tone in Humans
Hypertension, March 1, 2001; 37(3): 949 - 954.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. M. Givertz, D. B. Sawyer, and W. S. Colucci
Antioxidants and Myocardial Contractility : Illuminating the "Dark Side" of {{beta}}-Adrenergic Receptor Activation?
Circulation, February 13, 2001; 103(6): 782 - 783.
[Full Text] [PDF]


Home page
CirculationHome page
S. Mak and G. E. Newton
Vitamin C Augments the Inotropic Response to Dobutamine in Humans With Normal Left Ventricular Function
Circulation, February 13, 2001; 103(6): 826 - 830.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. J. Duffy, N. Gokce, M. Holbrook, L. M. Hunter, E. S. Biegelsen, A. Huang, J. F. Keaney Jr., and J. A. Vita
Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension
Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H528 - H534.
[Abstract] [Full Text] [PDF]